Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings in $30mm for NanoString Technologies

Executive Summary

NanoString Technologies (gene expression profiling technology) is plannining to raise $30mm through a two-tranche Series C venture round; it has brought in $15mm so far. New investor Clarus Ventures, which led the financing and contributes a board member, was joined by current shareholders OVP Venture Partners and Draper Fisher Jurvetson. The company will use the funds to commercialize its nCounter analysis system.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies